Ms. Berman will be responsible for the global clinical trial program at IlluminOss, including the U.S. Lightfix trial toward securing approval for the treatment of impeding and actual fractures of the humerus in patients with metastatic bone disease, according to a news release.
Prior to joining IlluminOss, Ms. Berman was at Cordis, a Johnson & Johnson company, for nearly a decade where she held roles of increasing responsibility and oversaw various high-profile clinical research programs in the U.S., Europe and Japan.
Ms. Berman holds a master’s degree in public health from Columbia University.
More articles on executive moves:
Community Hospital Corporation names Jim Coleman SVP, Southeast hospital operations
Kauai hospital CEO Kathy Clark to retire
18 latest hospital, health system executive moves
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.